ArticleLeukemia2013
The importance of relative mutant level for evaluating impact on outcome of KIT, FLT3 and CBL mutations in core-binding factor acute myeloid leukemia.
C Allen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
71 papers cite itlatest 60 shown
this paperpooled ittrialcites it